Pope Pius XI, born Ambrogio Damiano Achille Ratti, was born to the wealthy owner of a silk factory on 31 May 1857 in Desio, Italy. He was ordained to the priesthood at the age of eighteen, at which time he began a long life devoted to study, peacekeeping, and the betterment of societies around the world. Pius XI is noted here for his contribution to the Roman Catholic Church's early twentieth century approach to issues regarding contraception and abortion, which was presented in his December 1930 encyclical "Casti Connubii."

The Supreme Court of California reversed the Superior Court of Fresno County's decision to dismiss the Turpins' claims in the case Turpin v. Sortini on 3 May 1982. The case was based upon a wrongful life claim, in which a disabled child sues physicians for neglecting to inform its parents of potential genetic defects, resulting in harm to the child when it is born. The Turpin case determined tha a physician could be liable for failing to inform parents of potential birth defects in the fetus. It further concluded that a minor has grounds to sue for medical malpractice committed when it was an embryo or fetus.

The National Embryo Donation Center (NEDC) is a non-profit organization that was established in 2002 in Knoxville, Tennessee. The organization is endorsed and supported by several Christian-based associations such as the Christian Medical Association, Bethany Christian Services, and Baptist Health Systems. Its goal is to provide embryo donation and embryo adoption services in order to utilize the large number of embryos that are being cryopreserved as a result of infertility procedures and are no longer needed. Jeffrey Keenan, Medical Director of the NEDC, is an OB/GYN, reproductive endocrinologist, and infertility specialist.

Advanced Cell Technology, Inc. (ACT) is a biotechnology company that uses stem cell technology to develop novel therapies in the field of regenerative medicine. Formed in 1994, ACT grew from a small agricultural cloning research facility located in Worcester, Massachusetts, into a multi-locational corporation involved in using both human embryonic stem cells (hESC) and human adult stem cells as well as animal cells for therapeutic innovations. Through its work in developing alternative methods for hESC derivation and its public statements, ACT has also played an active role in stimulating and participating in public debate over stem cell research.

Post-coital oral emergency contraception is used for the prevention of pregnancy after intercourse. The contraception comes in the form of pills, often collectively referred to as morning-after pills. Post-coital use of morning-after pills separates them from traditional contraception which is either a continual preventative process, such as the birth control pill, or used during intercourse, such as condoms. Oral emergency contraception is important to embryology because it represents a significant accomplishment in the human ability to manipulate the process of embryonic development and pregnancy. Though there are still many misunderstandings about the morning-after pills as a contraceptive method, the continued efforts of scientists to carry out research on emergency contraception suggests that the technology may continue to improve and grow into more widespread use.

Throughout history many different methods have been devised for the early detection of pregnancy. From the time of the Ancient Egyptians, inspection of the urine has been a popular place to start. However, it was not until the discovery of hormones in the early twentieth century that the development of truly reliable pregnancy tests occurred. Prior to 1978, when the first home pregnancy tests became available in the United States, pregnancy testing was done in hospital laboratories using various methods, one of them being the Aschheim-Zondek, or A-Z test.

Prenatal exposure to alcohol (ethanol) results in a continuum of physical, neurological, behavioral, and learning defects collectively grouped under the heading Fetal Alcohol Spectrum Disorder (FASD). Fetal Alcohol Syndrome (FAS) is part of this group and was first defined in 1973 as a condition characterized by pre- and postnatal growth deficiencies, facial abnormalities and defects of the central nervous system (CNS). The CNS is particularly vulnerable to the effects of ethanol during prenatal development. Severe exposure correlates with gross morphological abnormalities and an overall decrease in white matter. Mechanisms for how ethanol affects the development of the CNS are complicated, but damage to neural stem cell progenitor pools that give rise to neurons and glia is strongly suspected to be a major factor. Damage to this population of cells at any point during CNS development can result in abnormalities in the formation and maturation of these cells, from the initial differentiation through the maturation of neuronal networks. This damage can lead to a wide variety of cognitive deficiencies, functional impairments, and behavioral problems depending on the area of the brain impacted by prenatal ethanol exposure.

The extraembryonic membranes that surround and originate from the embryos of vertebrates such as birds, reptiles, and mammals are crucial to their development. They are integral to increasing the surface area of the uterus, forming the chorion (which in turn produces the placenta) and the amnion, respectively. The amnion will ultimately surround the embryo in a fluid-filled amniotic cavity. This amniotic fluid, which cushions and protects the fetus and helps prevent the onset of labor, is sampled in amniocentesis to screen for genetic diseases.

The term Fetal Alcohol Syndrome (FAS) was first published in 1973 in an article published in the British medical journal The Lancet. In that article, a group of pediatricians and psychiatrists at the University of Washington Medical School helped to define the morphological defects and developmental delays that can affect children born to alcoholic mothers. Those observations include pre- and post-natal growth deficiencies, minor facial abnormalities, and damage to the developing brain that can result in behavioral, learning, and cognitive abnormalities.

Various techniques constitute assisted reproduction, one of which is gamete intra-fallopian transfer (GIFT). The first example of GIFT involved primates during the 1970s; however, the technology was unsuccessful until 1984 when an effective GIFT method was invented by Ricardo Asch at the University of Texas Health Sciences Center and the procedure resulted in the first human pregnancy. The GIFT technique was created in hopes of generating an artificial insemination process that mimicked the physiological sequences of normal conception. The technique was further advanced at the Center for Reproductive Health at the University of California, Irvine, when Asch and his associate Jose Balmaceda employed a newly developed catheter into the GIFT procedure that eliminated the need for general anesthesia in the later stages of the procedure.